PolyU hosts AI & Medicine: Shaping the Future of Health Forum, featuring a Nobel Laureate and an expert to explore the future of AI-driven medicine

The Hong Kong Polytechnic University (PolyU) Faculty of Computer and Mathematical Sciences, Faculty of Health and Social Sciences, and Faculty of Science today co-hosted the “AI & Medicine: Shaping the Future of Health” Forum. The event featured a keynote speech by Prof. Barry MARSHALL, 2005 Nobel Laureate in Physiology or Medicine, who shared his research journey and provided insights into the future of medicine. Prof. Ya-Qin ZHANG, Chair Professor of AI Science and Dean of the Institute for AI Industry Research (AIR) of Tsinghua University also participated in the panel discussion. The event attracted about 500 faculty members, students, alumni, leaders from the innovation and technology sectors, academia, and members of the public, fostering academic exchange and inspiring the pursuit of innovation.

Prof. Jin-Guang TENG, PolyU President expressed his gratitude to Prof. Marshall and Prof. Zhang for sharing their insights, which greatly benefited both faculty members and students. He remarked, “Artificial intelligence (AI) is pivotal in shaping the future of medicine. This Forum has provided a valuable platform for all to explore the evolving trends of AI in medicine and to collaborate for a healthier future. PolyU is making significant strides in leveraging the integration of AI into medical science by developing innovative healthcare solutions and collaborating with industry to translate research outcomes into real-world solutions that benefit society. Earlier this year, PolyU established the Faculty of Computer and Mathematical Sciences to strengthen interdisciplinary research and education in the areas of AI, data science and computing. These efforts lay a solid foundation for the University to realise its  commitment to establishing Hong Kong’s proposed third medical school.”

Prof. Marshall is currently Professor and Senior Honorary Research Fellow of the School of Biomedical Sciences, and Director of the Marshall Centre for Infectious Diseases Research and Training at The University of Western Australia; PolyU Distinguished Honorary Professor; and Chair Professor of Shenzhen University. In the early 1980s, Prof. Marshall and Australian pathologist Dr J. Robin WARREN discovered that gastritis and peptic ulcers were due to Helicobacter pylori (H. pylori). This groundbreaking research earned them the 2005 Nobel Prize in Physiology or Medicine and is widely regarded as the most significant discovery in the history of gastroenterology.

During his keynote speech, titled “Theory and Practice: Innovation and Curiosity Driven Research”, Prof. Marshall shared his pioneering work on H. pylori. He discussed the infection pathways and treatment methods of the bacterium, as well as his personal experience of drinking a culture of H. pylori to validate his research. His contributions continue to advance global healthcare, particularly in the field of gastrointestinal disease research.

In recent years, AI has emerged as a powerful tool in medicine, offering unprecedented opportunities to enhance patient care, streamline clinical processes and drive innovative research. During the panel discussion hosted by Prof. Hongxia YANG, Associate Dean (Global Engagement) of the PolyU Faculty of Computer and Mathematical Sciences, and Professor of the Department of Computing, Prof. Marshall and Prof. Ya-Qin Zhang discussed the future development of AI technology in medicine and education.

Prof. Marshall said, “AI is revolutionising our ability to diagnose diseases, personalise treatments and predict patient outcomes with unprecedented accuracy. By harnessing vast amounts of data, AI enables us to uncover insights that were previously beyond our reach, ultimately improving patient care and advancing medical research.”

Prof. Zhang said, “The field of life sciences and biomedicine has entered the era of Digitalisation 3.0, where AI plays a pivotal role, driving advancements toward greater speed, precision, safety, cost-effectiveness, and accessibility. Notable achievements have been made in areas such as protein structure prediction, gene editing, and drug discovery. However, challenges remain in terms of algorithm transparency, interpretability, security, privacy, and ethics. The AIR of Tsinghua University has pioneered the launch of an AI hospital and open-sourcing an AI-powered drug discovery platform, paving the way for biological research to enter the Autopilot era. Moving forward, we hope that academia and industry will further strengthen collaboration, driving the development of a closed-loop ecosystem and uncovering more opportunities for scientific and industrial innovation.”

During the Forum, the opening ceremony of the PolyU Marshall Research Centre for Medical Microbial Biotechnology was also performed. Prof. MA Cong, Associate Professor of the PolyU Department of Applied Biology and Chemical Technology, will serve as the Centre Director, with Prof. Marshall as a member of its Management Committee. The Centre aspires to advance the diagnosis and treatment of bacterial infections, such as H. pylori, the most common chronic bacterial infection globally, while leveraging Prof. Marshall’s groundbreaking research to establish AI-driven e-biobanks. These efforts will enhance research capabilities and enable more precise diagnostics. The Centre will also address the urgent need for novel antibiotics, due to rising drug resistance, by developing unique antimicrobial therapies with distinct mechanisms. Prof. Marshall stated that the establishment of the Centre will undoubtedly play a pivotal role in pioneering innovative solutions and fostering collaboration in this dynamic field.

***END***